Table 4.
*Log-rank test; †highly suspicious of EGFR mutation, clinically based on adenocarcinoma histology and never-smoking history. NSCLC, non-small cell lung cancer; CSF, cerebrospinal fluid; EGFR-TKI, epidermal growth factor receptor-tyrosine kinase inhibitor; LM, leptomeningeal metastasis; MS, median survival.